CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A...Consulting Agreement • May 5th, 2023 • Viracta Therapeutics, Inc. • Pharmaceutical preparations
This consulting agreement (“Agreement”) is made by and between VIRACTA THERAPEUTICS, INC., having a place of business at 2533 South Coast Hwy 101, Suite 210, Cardiff, CA 92007 USA, together with its affiliates (“Company”) and Lisa Rojkjaer, M.D., an individual with a place of business at [***] (“Consultant”), effective on the 5th day of May, 2023 at 4:59pm PDT (one minute before the effective date and time of Consultant’s resignation from her former position as Chief Medical Officer of the Company such that there is no break in service) for the purpose of setting forth the exclusive terms and conditions by which Company will acquire Consultant’s services on a temporary basis.
